| Authors: |
Anginot A; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Nguyen J; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; Inflammation, Microbiome and Immunosurveillance, INSERM, Université Paris-Saclay, Orsay, France., Abou Nader Z; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Rondeau V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Bonaud A; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Kalogeraki M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Boutin A; Université Côte d'Azur, CNRS, LP2M, Nice, France., Lemos JP; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Bisio V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Koenen J; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; Inflammation, Microbiome and Immunosurveillance, INSERM, Université Paris-Saclay, Orsay, France., Hanna Doumit Sakr L; Université Paris Cité, BIOSCAR Inserm U1132, Department of Rheumatology and Reference Center for Rare Bone Diseases, AP-HP Hospital Lariboisière, Paris, France., Picart A; Université Paris Cité, BIOSCAR Inserm U1132, Department of Rheumatology and Reference Center for Rare Bone Diseases, AP-HP Hospital Lariboisière, Paris, France., Coudert A; Université Paris Cité, BIOSCAR Inserm U1132, Department of Rheumatology and Reference Center for Rare Bone Diseases, AP-HP Hospital Lariboisière, Paris, France., Provot S; Université Paris Cité, BIOSCAR Inserm U1132, Department of Rheumatology and Reference Center for Rare Bone Diseases, AP-HP Hospital Lariboisière, Paris, France., Dulphy N; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Aurrand-Lions M; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.; Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Mancini SJC; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Lazennec G; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; CNRS, SYS2DIAG-ALCEDIAG, Cap Delta, Montpellier, France., McDermott DH; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Guidez F; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1131, Paris, France., Blin-Wakkach C; Université Côte d'Azur, CNRS, LP2M, Nice, France., Murphy PM; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Cohen-Solal M; Université Paris Cité, BIOSCAR Inserm U1132, Department of Rheumatology and Reference Center for Rare Bone Diseases, AP-HP Hospital Lariboisière, Paris, France., Espéli M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Rouleau M; Université Côte d'Azur, CNRS, LP2M, Nice, France., Balabanian K; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France. karl.balabanian@inserm.fr.; CNRS, GDR3697 'Microenvironment of tumor niches', Micronit, France. karl.balabanian@inserm.fr.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France. karl.balabanian@inserm.fr. |
